☆ 4.5 Article

Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort

RMD OPEN (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Critical Care Medicine

Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

Ganesh Raghu et al.

Summary: This article provides updates on the guidelines for idiopathic pulmonary fibrosis (IPF) and addresses the progression of pulmonary fibrosis in patients with interstitial lung diseases (ILDs) other than IPF. The recommendations are based on consensus and systematic reviews, aiming to provide evidence-based guidance for clinicians.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

添加到收藏夹

Article Rheumatology

Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies

Lorenzo Cavagna et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2022)

添加到收藏夹

Article Allergy

Thoracic Involvement in Systemic Autoimmune Rheumatic Diseases: Pathogenesis and Management

Elena De Zorzi et al.

Summary: Thoracic involvement is a major determinant of morbidity and mortality in patients with autoimmune rheumatic diseases. Interstitial lung disease is the most common pulmonary complication, while other manifestations include pulmonary arterial hypertension, airway disease, and pleural involvement. Treatment mainly focuses on immunosuppression, but further research is needed for a better understanding of the pathogenesis and development of more effective therapies.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2022)

添加到收藏夹

Article Respiratory System

Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry

Nathan Hambly et al.

Summary: The study found that PF-ILD is common in patients with fibrotic ILD, with varying progression patterns among different subtypes. Background treatments differ significantly among subtypes, and several factors are independently associated with disease progression.

EUROPEAN RESPIRATORY JOURNAL (2022)

添加到收藏夹

Article Respiratory System

Prevalence and prognosis of chronic fibrosing interstitial lung diseases with a progressive phenotype

Reoto Takei et al.

Summary: This study found that over one-fourth of non-IPF FILD patients develop a progressive phenotype compared to approximately 60% of IPF patients. The survival of non-IPF FILD patients with a progressive phenotype is similar to IPF.

RESPIROLOGY (2022)

添加到收藏夹

Article Rheumatology

Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort

Elisabetta Zanatta et al.

Summary: This study found that patients with positive anti-topoisomerase I (ATA) in limited cutaneous systemic sclerosis (lcSSc) have a high risk of interstitial lung disease (ILD), although the risk of progression is lower. Careful screening for ILD is necessary in this subgroup.

RHEUMATOLOGY (2022)

添加到收藏夹

Article Rheumatology

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database

Anna-Maria Hoffmann-Vold et al.

Summary: This study utilized data from the European Scleroderma Trials And Research (EUSTAR) database to analyze the disease course, progression patterns, and predictive factors for progressive interstitial lung disease (ILD) in patients with systemic sclerosis-associated ILD (SSc-ILD). The results showed that male sex, higher modified Rodnan skin score, and reflux/dysphagia symptoms were the strongest predictive factors for forced vital capacity (FVC) decline over a 5-year period in SSc-ILD patients.

ANNALS OF THE RHEUMATIC DISEASES (2021)

添加到收藏夹

Article Clinical Neurology

The significance of myositis autoantibodies in idiopathic inflammatory myopathy concomitant with interstitial lung disease

Hung-Ling Huang et al.

Summary: This study identified factors associated with interstitial lung disease (ILD) in patients with idiopathic inflammatory myopathy (IIM) based on the latest classification and recent advances in autoantibody serology. The presence of mechanic's hand, older age of onset, and specific autoantibodies were significantly associated with ILD in IIM patients. The study results may help physicians in timely screening and monitoring pulmonary function in high-risk groups like those with overlap myositis (OM) and dermatomyositis (DM).

NEUROLOGICAL SCIENCES (2021)

添加到收藏夹

Letter Respiratory System

The burden of Progressive Fibrotic Interstitial lung disease across the UK

Thomas Simpson et al.

EUROPEAN RESPIRATORY JOURNAL (2021)

添加到收藏夹

Article Medicine, General & Internal

HIV Stigma and Discrimination: Perspectives and Personal Experiences of Healthcare Providers in Yogyakarta and Belu, Indonesia

Nelsensius Klau Fauk et al.

Summary: The study revealed that healthcare providers believe that HIV stigma and discrimination still exist within families, communities, and healthcare settings, reflected in negative labeling, separation of personal belongings, avoidance, and denial of treatment. The findings suggest the importance of ongoing HIV/AIDS education for families, community members, and healthcare providers to raise awareness and ensure the establishment of healthy and professional support systems for PLWHA.

FRONTIERS IN MEDICINE (2021)

添加到收藏夹

Review Rheumatology

Role of antifibrotics in the management of idiopathic inflammatory myopathy associated interstitial lung disease

Erin M. Wilfong et al.

Summary: Nintedanib and pirfenidone, approved in 2014 by the United States for idiopathic pulmonary fibrosis, have shown promise in treating progressive fibrosing interstitial lung disease. While antifibrotic therapies may be useful as an adjuvant to traditional immunosuppression in IIM, there is a lack of randomized controlled trials in this specific condition.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2021)

添加到收藏夹

Review Medicine, General & Internal

High-Resolution CT Findings of Myositis-Related Interstitial Lung Disease

Ryoko Egashira

Summary: Myositis-related interstitial lung disease can be divided into chronic to subacute type and acute type, each presenting with different patterns of lesions. Early detection of rapid progression is crucial, and the presence of multiple randomly distributed ground-glass opacifications may indicate a poorer prognosis.

MEDICINA-LITHUANIA (2021)

添加到收藏夹

Article Allergy

Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis

Tamara Vojinovic et al.

Summary: Interstitial lung disease (ILD) occurs in about one third of patients with idiopathic inflammatory myositis (IIM), predominantly affecting those with anti-synthetase syndrome. ILD patterns in IIM patients include non-specific interstitial pneumonia (NSIP), organizing pneumonia (OP), and usual interstitial pneumonia-like (UIP). ILD onset is associated with dyspnea and anti-Ro52 antibodies, with the latter predicting a significant improvement in DLCO during follow-up.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2021)

添加到收藏夹

Review Rheumatology

Systemic sclerosis: Recent insight in clinical management

Elisabetta Zanatta et al.

JOINT BONE SPINE (2020)

添加到收藏夹

Review Respiratory System

Predictors of progression in systemic sclerosis patients with interstitial lung disease

Oliver Distler et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Anti-Ro52 antibody is an independent risk factor for interstitial lung disease in dermatomyositis

Xiaojing Xing et al.

RESPIRATORY MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

K. R. Flaherty et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Editorial Material Respiratory System

Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases

Vincent Cottin

EUROPEAN RESPIRATORY REVIEW (2019)

添加到收藏夹

Review Rheumatology

Pulmonary involvement in antisynthetase syndrome

Michela Gasparotto et al.

CURRENT OPINION IN RHEUMATOLOGY (2019)

添加到收藏夹

Review Respiratory System

The natural history of progressive fibrosing interstitial lung diseases

Martin Kolb et al.

RESPIRATORY RESEARCH (2019)

添加到收藏夹

Article Rheumatology

Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features

Anna-Maria Hoffmann-Vold et al.

RMD OPEN (2019)

添加到收藏夹

Review Rheumatology

New insights in myositis-specific autoantibodies

Anna Ghirardello et al.

CURRENT OPINION IN RHEUMATOLOGY (2018)

添加到收藏夹

Review Respiratory System

Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases

Vincent Cottin et al.

EUROPEAN RESPIRATORY REVIEW (2018)

添加到收藏夹

Article Rheumatology

2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups

Ingrid E. Lundberg et al.

ANNALS OF THE RHEUMATIC DISEASES (2017)

添加到收藏夹

Review Immunology

Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study

Lucile Musset et al.

AUTOIMMUNITY REVIEWS (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Pirfenidone in patients with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis

Ting Li et al.

SCIENTIFIC REPORTS (2016)

添加到收藏夹

Article Immunology

The clinical features, diagnosis and classification of dermatomyositis

Luca Iaccarino et al.

JOURNAL OF AUTOIMMUNITY (2014)

添加到收藏夹

Review Immunology

Myositis autoantibodies and clinical phenotypes

Anna Ghirardello et al.

AUTOIMMUNITY HIGHLIGHTS (2014)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.